<code id='2A684BD360'></code><style id='2A684BD360'></style>
    • <acronym id='2A684BD360'></acronym>
      <center id='2A684BD360'><center id='2A684BD360'><tfoot id='2A684BD360'></tfoot></center><abbr id='2A684BD360'><dir id='2A684BD360'><tfoot id='2A684BD360'></tfoot><noframes id='2A684BD360'>

    • <optgroup id='2A684BD360'><strike id='2A684BD360'><sup id='2A684BD360'></sup></strike><code id='2A684BD360'></code></optgroup>
        1. <b id='2A684BD360'><label id='2A684BD360'><select id='2A684BD360'><dt id='2A684BD360'><span id='2A684BD360'></span></dt></select></label></b><u id='2A684BD360'></u>
          <i id='2A684BD360'><strike id='2A684BD360'><tt id='2A684BD360'><pre id='2A684BD360'></pre></tt></strike></i>

          fashion

          fashion

          author:explore    Page View:324

          The Senate has set its eyes on regulating insurance plans for some of the most vulnerable patients in the U.S. — the 12.5 million people eligible for both Medicare and Medicaid.

          “They’re a complex group of people with a lot of chronic conditions — mental illness, frailty, disability,” said Jose Figueroa, an internal medicine physician and health policy expert at Brigham and Women’s Hospital. Over a third of these dual-eligible beneficiaries have less than a high school education, and about 90% make less than $20,000 per year.

          advertisement

          Just around 15% of beneficiaries are eligible for both Medicare and Medicaid, but they account for a third of these programs’ spending — around $440 billion — and still don’t receive better health care, Sen. Bill Cassidy (R-La.) pointed out in a JAMA viewpoint published earlier this month. “The root cause of worse outcomes despite spending more money is a lack of coordination of care,” Cassidy wrote.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more
          Readout LOUD: Venture capital, Gilead, and more M&A
          Readout LOUD: Venture capital, Gilead, and more M&A

          AreventurecapitalistsOK?Arebolt-onsgoodforbusiness?Andwhenisitsafetosaysomeoneoverpaid?Wecoveralltha

          read more
          Affirmative action in medical school literally saved lives
          Affirmative action in medical school literally saved lives

          AdobeThepastseveralmonthshavebeengrimforhealthintheU.S.InDecember,theCentersforDiseaseControlandPrev

          read more

          Medicare Advantage plans can’t deny care with AI, CMS warns

          AdobeInrecentmonths,thefederalgovernmenthasrepeatedlytoldMedicareAdvantageinsurersthattheycannotusea